Viewing Study NCT05167851


Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2026-01-16 @ 3:28 PM
Study NCT ID: NCT05167851
Status: NOT_YET_RECRUITING
Last Update Posted: 2021-12-22
First Post: 2021-11-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer
Sponsor: Yonsei University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module